(Circulation. 1995;92:2072-2078.)
© 1995 American Heart Association, Inc.
Articles |
Impaired Myocardial Tissue Perfusion Early After Successful Thrombolysis
Impact on Myocardial Flow, Metabolism, and Function at Late Follow-up
Presented in part at the 67th Scientific Sessions of the American Heart Association, Dallas, Tex, November 1994.
From the Departments of Nuclear Medicine (A.M., L.M., J.N.), Cardiology (W.D., F.V.d.W.), and Pharmaceutical Sciences, F.F.W., (G.B.), University of Leuven, Belgium.
Correspondence to Frans Van de Werf, MD, PhD, Department of Cardiology, UZ Gasthuisberg, Herest 49, 3000 Leuven, Belgium.
 |
Abstract |
|---|
 Top Abstract IntroductionMethods Results Discussion References |
|---|
Background Impaired tissue reperfusion after successful recanalization of an epicardial coronary artery has been documented both in animals and in patients with acute myocardial infarction. Whether this phenomenon can be demonstrated with positron emission tomography (PET) and whether it has an effect on late recovery of flow, metabolism, and function are unknown.
Methods and Results Thirty patients with an acute myocardial infarction and TIMI flow grade 3 of the infarcted vessel at 90 minutes after thrombolytic therapy were studied. Within 24 hours after thrombolysis, at 5 days and at 3 months, myocardial blood flow was measured with 13NH3. 18FDG uptake was measured at 5 days. Radionuclide left ventricular angiograms were acquired at 5 days and at 3 months. In 11 patients (37%), regional myocardial flow was severely impaired (<50% of normally perfused myocardium) despite successful thrombolysis. No recovery of left ventricular function occurred in any of these patients at 3 months. In 12 patients (40%), intermediate flows (50% to 75% of normal) were found, with functional improvement after angioplasty only in regions with a PET mismatch. Seven patients (23%) had high flow values early after successful thrombolysis (>75% of normal) and showed preserved regional contractile function at 3 months.
Conclusions This study is the first demonstration with PET of impaired myocardial tissue perfusion in patients with an acute myocardial infarction after successful thrombolysis. Functional recovery of the reperfused myocardium is observed only when adequate tissue flow is restored. PET may be helpful in selecting patients in whom additional revascularization can improve recovery of left ventricular function.
Key Words: tomography • thrombolysis • reperfusion
|
Introduction |
|---|
|
TopAbstractIntroductionMethods Results Discussion References |
|---|
Temporary occlusion of a coronary artery causes reversible ischemic injury of the myocardium. As the duration of the occlusion prolongs, necrosis develops in an increasing number of myocytes. In canine studies it was demonstrated that viable myocardial tissue persists for at least 3 hours after the onset of ischemia.1 2 During this phase, restoration of flow can save ischemic but viable myocardial tissue.1 3 Interventions such as balloon angioplasty or thrombolysis can restore coronary flow in patients with an evolving myocardial infarction. Coronary angiography is mostly used to evaluate the success of reperfusion therapy. However, myocardial tissue perfusion may remain impaired despite restoration of flow in the previously occluded epicardial coronary artery.4 5 This failure to achieve adequate tissue reperfusion is referred to as "low reflow" or "no reflow" phenomenon.5 6 It is thought that impaired tissue reperfusion is already largely established at the time of reperfusion because of capillary damage induced by ischemia.4 7 8 However, reperfusion itself also appears to induce additional injury.9 For example, in some studies, a delayed, gradual fall in tissue flow has been observed in areas that initially showed adequate reperfusion.10 11 The presence of impaired myocardial tissue perfusion was recently demonstrated with contrast echocardiography in patients with anterior myocardial infarction after thrombolysis.12 Myocardial tissue flow also can be measured with positron emission tomography (PET).13 14 The aim of our study was to further investigate the presence of impaired tissue perfusion in patients after successful thrombolysis with the use of PET and to evaluate its effect on the recovery of flow, metabolism, and function at follow-up.
|
Methods |
|---|
|
TopAbstractIntroductionMethods Results Discussion References |
|---|
Patient Selection and Coronary Angiography
Patients with an acute myocardial infarction of less than 6-hour duration were prospectively studied. Patients with typical chest pain of more than 30 minutes and with ST segment elevations of
0.1 mV in
two or more limb leads or 0.2 mV in two or more contiguous
precordial leads were enrolled. Patients received either
recombinant staphylokinase or front-loaded alteplase with
intravenous heparin or streptokinase with either
intravenous or subcutaneous heparin, according to the
GUSTO-I protocol.15 16 All patients were given oral
aspirin. All patients underwent coronary angiography at 90 minutes after the start of thrombolytic therapy. A control angiography was performed at 24 hours (15 patients) or at 5 days (15 patients). The angiograms were read by two independent experienced angiographers. The patency of the infarct-related vessel was scored according to the Thrombolysis in Myocardial Infarction (TIMI) criteria of reperfusion.17 Only patients with a TIMI flow grade 3 both at 90 minutes and at follow-up were selected for the study. The study was approved by the ethical committee for human research of the University of Leuven.
Positron Emission Tomography
Myocardial blood flow was
measured with
13NH3 within 24 hours after the start of
thrombolytic treatment, at 5 days, and at 3 months. An
18FDG scan for the evaluation of metabolism was
performed at 5 days.
The perfusion studies and the perfusion/metabolism studies were performed with a whole-body positron emission tomograph (model 931-08/12, CTI Siemens) provided with eight detector rings permitting simultaneous acquisition of 15 planes, with an interplane spacing of 6.75 mm. A small cyclotron (cyclone 10/5, Ion Beam Applications) and auxiliary chemical processing equipment were used to produce 18FDG and 13NH3. Before each study, a 2-minute rectilinear scan, used for positioning the heart within the field of view, and a 15-minute transaxial transmission scan with a 68Ge ring source for photon attenuation correction were performed.
Myocardial perfusion was evaluated using 13NH3 ammonia: 20 mCi of 13NH3 in 5 mL saline followed by a 20-mL flush of saline was slowly infused at a constant rate of 10 mL/min. Acquisition was started simultaneously with the injection of 13NH3. In each patient, 19 dynamic frames were recorded (12x10 seconds, 4x30 seconds, 3x2 minutes). Total acquisition time was 10 minutes.
Regional
myocardial utilization of exogenous glucose was evaluated with
18FDG. The metabolic studies were performed
with use of the euglycemic hyperinsulinemic
clamp technique.18 19 The tracer dose of 10 mCi was
injected after stabilization of the glucose level between 85 and 95
mg% and not earlier than 50 minutes after
13NH3 injection to allow isotope decay. In each
patient, 22 dynamic frames were recorded (8x15 seconds, 4x30
seconds, 2x1 minutes, 2x2 minutes, 6x10 minutes). Total
acquisition
time was 70 minutes. The time required for image acquisition of the
combined 13NH3 and 18FDG study was
2
to 3 hours.
Kinetic Modeling
The first 19 frames of the perfusion studies
were reconstructed
using a Hanning filter with a cutoff frequency of 0.3. The long axis of
the left ventricle was indicated manually on the last frame. The
myocardial image was resampled into 16 radial slices. The radial slices
were delineated using an algorithm developed in our
department.20 21 The delineation was used to
construct a
polar map for every frame. Each polar map was divided into 33 regions:
four rings of eight regions and one region for the apex. Absolute flow
values were obtained using a three-compartment
model.14 Flow values were normalized: A flow index was
calculated as the ratio of the flow in the infarcted area divided by
the flow in the normally perfused area.
The 22 frames of the metabolic study were reconstructed using a Hanning 0.4 filter. The creation of radial slices, delineation, polar maps, and regional time activity was done in the same way as for the flow studies. Regional glucose utilization was estimated by application of a PATLAK graphical analysis22 23 using frames 8 to 22. The region in which flow was considered to be normal was used as reference region for 18FDG. 18FDG values were normalized: A metabolic index was defined as the ratio of the glucose utilization in the infarct area over that in the normal zone.
Based on values obtained in normal volunteers, myocardium was supposed to demonstrate a mismatch pattern if the ratio of the metabolic and flow indexes was higher than 1.2.24 25
Radionuclide Angiography
Radionuclide angiography was
performed at 5 days and at 3
months. Red blood cells were labeled with 20 mCi of 99mTc.
Ten minutes after the injection, an equilibrium gated nuclear
angiography was acquired during 10 minutes while the patient was
positioned under the gamma camera in a left anterior oblique 45-degree
position for visualization of septum, apex, and posterolateral wall. A
low-energy, all-purpose collimator was used. The same study was
repeated in a left anterior oblique 70-degree position for
visualization of anterior wall, apex, and left part of the
inferior wall and in an anterior position for visualization
of lateral wall, apex, and right part of inferior wall.
Global and regional ejection fractions were calculated automatically
with the use of standard software (Sopha Medical Benelux). The software
was validated with 88 gated bloodpool data sets from the Mayo Clinic
(Rochester, Minn.) (y=0.87x+6.2,
r=.92, x=Mayo Clinic software,
y=Sopha
program, SEE=5.5, n=88). A region corresponding to the infarct
zone was
chosen for evaluation of regional ejection fraction. The same region
was used at 3 months for comparison with the 5 day values.
Statistical Analysis
Results are given as mean
value±SD. Differences between groups
were investigated with the use of ANOVA followed by post hoc testing
(Tukey's honestly significant difference, Tukey HSD).26
Intragroup comparisons were performed using Student's t
tests for paired data with Bonferroni correction. For evaluation of the
relationship between flow and both global and regional left
ventricular functions, linear regression plots were used.
Differences between correlation coefficients were tested using
Fisher's z transformations.
|
Results |
|---|
|
TopAbstractIntroductionMethods Results Discussion References |
|---|
Clinical, Angiographic, and PET Data
Thirty-two patients with a TIMI flow grade 3 patent infarct vessel at 90 minutes were considered for the study. Of these, 2 patients were excluded because of reocclusion at the time of the control angiography. Thus, 30 patients with a TIMI flow grade 3 open infarct vessel at 90 minutes and at follow-up were submitted to the entire study protocol. Clinical characteristics at entry and angiographic results at 90 minutes in all patients are listed in Table 1
. Individual flow and metabolism results of
all patients at the different time points are given in Table 2.
When all patients are considered, normalized flow in
the infarcted zone shortly after thrombolysis was 60±7%
on average. At 5 days and 3 months, slightly higher flow values were
measured (P=NS). Normalized FDG uptake at 5 days was
65±21%. A poor linear relationship
(y=0.7x+19, r=.497,
P<.05) was present between blood flow and
metabolism at this time point. In 22 patients (73%), the
decrease of metabolism and flow was concordant (PET match),
while in 8 patients (27%) a PET mismatch (decreased flow with
preservation of FDG uptake) was found.
|
|
Patients were arbitrarily
divided post hoc into three groups according
to flow values at 24 hours. Patients with a flow index of <50% of the
reference zone were defined to have severely impaired reflow (group A).
Patients with a flow index between 50% and 75% were considered to
have a moderately decreased flow (group B), and patients with a flow
index of >75% were considered to have adequate tissue reperfusion
(group C). Eleven patients (37%) were included in group A. Twelve
patients (40%) had intermediate flow values (group B), and 7 (23%)
revealed high flows (group C). Clinical characteristics of the three
groups are listed in Table 1
. Although the differences were not
statistically significant, peak creatine kinase values were higher in
group A (1841±442 U/L) than in group B (1485±277 U/L) or in
group C
(1199±411 U/L), and the time between the onset of symptoms and the
start of treatment tended to be longer in group A (194±35 minutes)
than in group B (163±41 minutes) or in group C (147±58 minutes).
No
collaterals to the infarcted area were visible on the angiogram at 90
minutes or at follow-up in any of these patients who all had an
open infarct–related vessel on both occasions. None of the
patients suffered a reinfarction. Fourteen of the 30 patients (5 in
groups A and B and 4 in group C) underwent balloon angioplasty after
day 5 because of a severe residual stenosis.
In group A (n=11),
similar flow values were found at 24 hours and 5
days (Table 2). Eight patients revealed a PET match, whereas a
PET
mismatch was found in 3. In group B (n=12), flow values at 5 days were
also very similar to those at 24 hours. Four of these patients revealed
a mismatch pattern, and in eight a match pattern was observed. In group
C (n=7), high flow values were measured both at 24 hours and at 5 days.
In one of these patients a mismatch pattern was found, whereas the
others showed a match pattern.
Twenty-five patients underwent a control
PET study at 3 months
(Table 2). Five patients (4 from group A and 1 from group B)
refused
this control examination. Flow values at 3 months in group A were
similar to those obtained at 5 days. High flow values in group C
persisted at 3 months. Flow values in group B tended to be higher at 3
months compared with the results at 24 hours and at 5 days. Statistical
analysis revealed no significant differences between flow
values at 24 hours, 5 days, and 3 months in any of the three
groups.
A significant difference in flow was found between group A and
both
other groups and between group B and group C at 5 days (ANOVA,
P<.00001; Tukey HSD, P<.01). At 3 months, a
significant difference in flow was found between group A and both other
groups but not between group B and group C (ANOVA, P<.001;
Tukey HSD, P<.01). Since patients were arbitrarily divided
into groups according to normalized flow values at 24 hours, no
statistical analysis was performed on the 24-hour flow data
(Table 2).
Left Ventricular Function
In 24 patients, left ventricular
function was
evaluated by means of radionuclide ventriculography at 5 days and 3
months. Six patients (3 of group A, 3 of group B) refused control
ventriculography. Mean values for global and regional left
ventricular ejection fractions in all patients and in the
three groups are summarized in Table 3. In group A, mean
global and regional ejection fractions tended to be lower at 3 months
than at 5 days, whereas in group B and group C the opposite was
observed. These time-related changes, however, were not
statistically significant in any of the groups. Global and regional
ejection fractions increased from group A to group C both at 5 days and
at 3 months. At 5 days, regional ejection fraction of the infarct area
was significantly lower in group A as compared with group C (ANOVA,
P<.005; Tukey HSD, P<.05). At 3 months, a
significant difference was found between group A and both other groups
(ANOVA, P<.0001; Tukey HSD, P<.05). Similar
results were obtained when global ejection fractions were compared
(ANOVA, P<.0005; Tukey HSD, P<.05; both at 5
days and 3 months) (Fig 1). The differences in global
and regional ejection fraction between group B and group C were not
statistically significant at both time points.
|
|
, Individual values for global and regional ejection fractions.
ANOVA followed by post hoc testing (Tukey HSD) showed a significant
difference between group A and group C at 5 days. ANOVA followed by
post hoc testing (Tukey HSD) showed a significant difference between
group A and both group B and group C at 3 months.
Relationship Between Flow, Metabolism, and
Function
In Fig 2, the perfusion data at 24 hours, the
PET
pattern at 5 days, and the evolution of regional ejection fraction from
day 5 to 3 months are represented. Bold symbols in Fig 2
indicate in which patients balloon angioplasty was performed. Patients
in the low flow range (<50%) showed no functional improvement. All
had severely depressed regional contractile function at 3 months. In
the group with intermediate flow values (50% to 75%), only patients
with a mismatch pattern revealed functional improvement after
angioplasty (Table 2; Nos. 12, 14, and 19). In the high flow
range
(>75%), all patients revealed preserved contractile function in the
infarct region at 3 months. In some patients with high flow values at
24 hours, regional function further improved after 3 months (Table
2;
Nos. 24, 26, 28, and 29), without additional therapy.
|
The correlation
coefficient between flow and regional ejection
fraction increased significantly from .50 at 5 days to .77 at 3 months
(P<.05), whereas the correlation coefficient between flow
and global ejection fraction changed from .60 at 5 days to .73 at 3
months (P=NS) (Fig 3).
|
|
Discussion |
|---|
|
TopAbstractIntroductionMethods Results Discussion References |
|---|
Impairment of myocardial tissue perfusion after successful thrombolysis, the so-called "low reflow" and "no reflow" phenomenon, has been documented both in the experimental animal and in patients.5 6 12 It is thought that this phenomenon is mainly caused by vascular injury and that it occurs primarily at the time of reperfusion in irreversibly injured myocardium.5 Other observations lead to the conclusion that the presence of impaired perfusion after recanalization is also due in part to a late fall in flow to areas that initially were adequately reperfused.10 In the present study, the occurrence and duration of the low reflow or no reflow phenomenon after successful thrombolysis in patients with acute infarction and its possible impact on recovery of flow, metabolism, and function were examined with the use of PET and repeated scintigraphic evaluation of left ventricular function.
In more than one third of the patients (group A), an important perfusion defect was seen in the reperfused area early after successful thrombolysis (TIMI flow grade 3 of the infarct-related coronary artery). In these patients, no significant improvement of regional myocardial blood flow was found over time, and a significant difference in flow values between these patients and the other groups persisted both at 5 days and at 3 months. This finding indicates that successful recanalization with angiographically documented TIMI flow grade 3 is not necessarily associated with adequate tissue perfusion, hereby confirming recent findings obtained with contrast echocardiography in patients with an anterior infarction.12 Thus, this study in patients, for the first time documents with PET in a quantitative way the presence of severely reduced flow shortly after successful thrombolysis. Functional recovery was not observed in these patients at follow-up, and a severely depressed regional contractile function was present both at 5 days and at 3 months, regardless of the PET pattern at 5 days (match or mismatch). These findings are in concordance with the observation that an intact microvasculature is necessary for functional improvement.27 Our results can be viewed as an indication that a minimal level of capillary perfusion early after recanalization is required to allow for recovery of ventricular contractile function. Alternatively, the level of tissue perfusion after coronary thrombolysis also can be viewed as a reflection of the severity of the global injury resulting from preceding ischemia and reperfusion. In this view, the myocytes and the microvasculature are affected concordantly and the level of tissue perfusion is not a direct pathophysiological determinant of functional recovery. Whichever the relation between tissue perfusion and functional recovery, it is of interest to note that the longest treatment delay was observed in the group without recovery (group A). Although this finding was not statistically significant, it suggests that impaired or no reflow is less likely to occur in early reperfused myocardium and supports the concept that prolonged ischemia plays an important role in this phenomenon.
Patients with a moderate flow reduction (group B) showed functional improvement only when a PET mismatch pattern was present, and an additional revascularization procedure was performed. Further recovery of myocardial function in these patients with a mismatch pattern (indicative of the presence of viable but ischemically endangered myocardium) can explain the finding of significantly higher global and regional ejection fractions as compared with the group with severely impaired flow (group A) at 3 months. A significant flow difference was found between group B and the preserved flow group (group C) at 5 days but not at 3 months. This may be explained by an improvement of flow in patients of group B with a mismatch pattern undergoing additional revascularization because of a residual tight stenosis. It should be noted that, although FDG uptake is known to be a reliable indicator of viability and a good predictor of recovery in chronic situations,28 29 some studies suggest that FDG uptake might be seen both in viable and nonviable tissue in the acute phase, possibly as a result of white blood cell infiltration or membranous damage.30 In another study, however, it was stated that preserved FDG uptake is likely to reflect metabolism of viable myocytes and not leukocyte metabolism, supporting a possible diagnostic role for FDG in acute situations.31 In our study, functional recovery occurred only in patients with a mismatch pattern, suggesting that tissue viability was indeed present in these patients after 5 days. Thus, the combination of a perfusion level between 50% and 75% and a mismatch pattern at 5 days appears to indicate the possibility of further recovery of left ventricular function after additional revascularization. Perfusion levels alone in this group did not predict functional recovery, since a moderate flow deficit can indicate irreversible myocardial damage or insufficient reperfusion in viable myocardium caused by a tight coronary artery stenosis.
Patients with high flow values in the infarcted area at 24 hours (group
C) showed preserved contractile function at 3 months. In some patients
of this group a low regional ejection fraction was found at 5 days
despite high flow values in the infarcted area with further improvement
of regional ejection fraction at 3 months, without any additional
revascularization therapy. Thus, in these patients
myocardial blood flow was restored at 24 hours, thanks to
thrombolytic therapy, with a delayed functional recovery of
the "stunned" myocardium. This is in agreement with
previous findings in patients with reperfused anterior infarction in
whom functional improvement in reperfused areas was found only after 14
days to 1 month of reperfusion.32 33 In several other
studies it was also stated that functional recovery of stunned
myocardium requires several days or even weeks after
reperfusion.34 35 The recovery of stunned,
dysfunctional
myocardium after day 5 also explains the better linear
relationship between flow and regional left ventricular
function found at 3 months (Fig 3).
Study Limitations
All patients underwent a coronary
angiography at 90
minutes and had a control angiography at 24 hours or at 5 days. Only
patients with TIMI flow grade 3 at both time points were included in
this study. During follow-up, none of the patients had clinical or
ECG evidence of reinfarction. In none of the patients studied was there
observed a dramatic decrease in 13NH3 values
suggesting reocclusion at 3 months. Nevertheless, it cannot be excluded
that silent reocclusion occurred in some patients at a later time
point, which could have affected the recovery of left
ventricular function.36
In this study, 13NH3 was used as flow tracer. Flow values obtained with PET depend on the characteristics of the flow tracer used. Previous studies have shown that a good linear relationship exists between myocardial flow measured with microspheres and with 13NH3 over a large flow range, including necrotic myocardial regions, despite the presumed dependence of 13NH3 uptake on cell integrity.37 38
Clinical Implications
The present study demonstrates that the
degree of myocardial
tissue reperfusion as measured with PET within 24 hours after
successful thrombolysis has an important prognostic
significance. Patients with low flow values at 24 hours showed severely
impaired regional contractile function at follow-up, whereas high
flow values appear to predict good functional recovery at 3 months. Our
study, in a limited number of patients, suggests that in patients with
a moderate impairment of perfusion at 24 hours, a
flow/metabolism scan at 5 days may be useful for the
identification of viable but ischemically compromised
myocardium (PET mismatch). In these patients, functional
improvement can be obtained with additional
revascularization procedures. Future studies in a
larger group of patients are warranted to confirm the initial results.
Our study also suggests that PET may prove to be very useful for the
evaluation of additional therapies aimed at the improvement of the
microcirculation of the reperfused myocardium.
Conclusions
In this study, for the first time, the presence
of impaired reflow
after successful thrombolysis was demonstrated and
quantified with PET in patients with acute myocardial infarction. The
presence of adequate myocardial tissue perfusion early after successful
thrombolysis was clearly associated with functional
recovery at late follow-up.
|
Acknowledgments |
|---|
This study was supported in part by grant 6-0269-95 from the National Research Council of Belgium (NFW0).
Received March 20, 1995; revision received May 17, 1995; accepted May 22, 1995.
|
References |
|---|
|
TopAbstractIntroductionMethods Results Discussion References |
|---|
1. Reimer KA, Lowe JE, Rasmussen MM, Jennings RB. The wavefront phenomenon of ischemic cell death, I: myocardial infarct size versus duration of coronary occlusion in dogs. Circulation. 1977;56:786-794.
2. Reimer KA, Jennings RB. The wavefront phenomenon of myocardial ischemic cell death, II: transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow. Lab Invest. 1979;40:633-644. [Medline] [Order article via Infotrieve]
3. Maroko PR, Libby P, Ginks WR, Bloor CM, Shell WE, Sobel BE, Ross J Jr. Coronary artery reperfusion, I: early effects on local myocardial function and the extent of myocardial necrosis. J Clin Invest. 1972;51:2710-2716.
4.
Krug A, deRochemont WM, Korb G. Blood supply of
the myocardium after temporary coronary
occlusion. Circ Res. 1966;19:57-62.
5. Kloner RA, Ganote CE, Jennings RB. The `no reflow' phenomenon after temporary coronary occlusion in the dog. J Clin Invest. 1974;54:1496-1508.
6.
Willerson JT, Watson JT, Templeton GH, Fixler DE.
Reduced myocardial reflow and increased coronary
vascular resistance following prolonged myocardial ischemia in
the dog. Circ Res. 1975;36:771-781.
7.
Vanhaecke J, Flameng W, Borgers M, Jang I, Van de Werf
F, De Geest H. Evidence for decreased coronary flow
reserve in viable postischemic
myocardium. Circ Res. 1990;67:1201-1210.
8.
Fishbein MC, Y-Rit J, Lando U, Kanmatsuse K, Mercier
JC, Ganz W. The relationship of vascular injury and myocardial
hemorrhage to necrosis after reperfusion.
Circulation. 1980;62:1274-1279.
9. Becker LC, Ambrosio G. Myocardial consequences of reperfusion. Prog Cardiovasc Dis. 1987;30:23-44. [Medline] [Order article via Infotrieve]
10.
Ambrosio G, Weisman HF, Mannisi JA, Becker LC.
Progressive impairment of regional myocardial perfusion after
initial restoration of postischemic blood flow.
Circulation. 1989;80:1846-1861.
11. Jeremy RW, Links JM, Becker LC. Progressive failure of coronary flow during reperfusion of myocardial infarction: documentation of the no reflow phenomenon with positron emission tomography. J Am Coll Cardiol. 1990;16:695-704. [Abstract]
12.
Ito H, Tomooka T, Sakai N, Yu H, Higashino Y, Fujii K,
Masuyama T, Kitabatake A, Minamino T. Lack of myocardial
perfusion immediately after successful
thrombolysis. Circulation. 1992;85:1699-1705.
13.
Kuhle WG, Porenta G, Huang S, Buxton D, Gambhir SS,
Hansen H, Phelps ME, Schelbert HR. Quantification of regional
myocardial blood flow using 13N-ammonia and reoriented dynamic positron
emission tomographic imaging. Circulation. 1992;86:1004-1017.
14.
Muzik O, Beanlands RS, Hutchins GD, Mangner TJ, Nguyen
N, Schwaiger M. Validation of nitrogen-13-ammonia tracer kinetic
model for quantification of myocardial blood flow using PET.
J Nucl Med. 1993;34:83-91.
15.
GUSTO Investigators. An international randomized
trial comparing four thrombolytic strategies for acute
myocardial infarction. N Engl J Med. 1993;329:673-682.
16.
Collen D, Van de Werf F. Coronary
thrombolysis with recombinant staphylokinase in patients
with evolving myocardial infarction.
Circulation. 1993;87:1850-1853.
17. TIMI Study Group. The thrombolysis in myocardial infarction (TIMI) trial. N Engl J Med. 1985;312:932-936. [Medline] [Order article via Infotrieve]
18.
Knuuti JM, Nuutila P, Ruotsalainen U, Saraste M,
Harkonen R, Ahonen A, Teras M, Haaparanta M, Wegelius U, Haapanen A,
Hartalia J, Voipio-Pulkki L. Euglycemic
hyperinsulinemic clamp and oral glucose load in
stimulating myocardial glucose utilization during positron emission
tomography. J Nucl Med. 1992;33:1255-1262.
19.
DeFranzo RA, Tobin JD, Andres R. Glucose clamp
technique: a method for quantifying insulin secretion and
resistance. Am J Physiol. 1979;237:E214-E223.
20. Nuyts J, Suetens P, Oosterlinck A, De Roo M, Mortelmans L. Delineation of ECT images using global constraints and dynamic programming. IEEE Trans Med Imaging. 1991;10:489-498.
21.
Maes A, Flameng W, Nuyts J, Borgers M, Shivalkar B,
Ausma J, Bormans G, Schiepers C, De Roo M, Mortelmans L.
Histological alterations in chronically
hypoperfused myocardium: correlation with PET
findings. Circulation. 1994;90:735-745.
22. Patlak CS, Blasberg RG, Fenstermacher JD. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab. 1983;3:1-7. [Medline] [Order article via Infotrieve]
23. Patlak CS, Blasberg RG. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data generalizations. J Cereb Blood Flow Metab. 1985;5:584-590. [Medline] [Order article via Infotrieve]
24. De Landsheere C, Raets D, Pierard L, Degueldre C, Legrand V, Lemaire C, Guillaume M, Lamotte D, Kulbertus HE, Rigo P. Regional myocardial perfusion and glucose uptake: clinical experience in 92 cases studied with positron tomography. In: Schmidt HAE, Chambron J, eds. Nuclear Medicine: Quantitative Analysis in Imaging and Function. Stuttgart, Germany: Schattaue Verlag; 1990:245-247.
25.
Vanoverschelde JL, Wijns W, Depre C, Essamri B,
Heyndrickx GR, Borgers M, Bol A, Melin JA. Mechanisms of chronic
regional postischemic dysfunction in humans: new insights
from the study of noninfarcted collateral-dependent
myocardium. Circulation. 1993;87:1513-1523.
26. Hays WL. Comparisons among means. In: Statistics. Orlando, Fla: Holt, Rinehart and Wilson Inc; 1988;11:418-421.
27.
Ragosta M, Camarano G, Kaul S, Powers ER, Sarembock IJ,
Gimple LW. Microvascular integrity indicates myocellular
viability in patients with recent myocardial infarction: new insights
using myocardial contrast echocardiography.
Circulation. 1994;89:2562-2569.
28. Pierard LA, DeLandsheere CM, Berthe C, Rigo P, Kulbertus HE. Identification of viable myocardium by echography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: comparison with positron emission tomography. J Am Coll Cardiol. 1990;15:1021-1031. [Abstract]
29. Tamaki N, Yonekura Y, Yamashita K, Saji H, Magata Y, Senda M, Konishi Y, Hirata K, Ban T, Konishi J. Positron emission tomography using fluorine-18 deoxyglucose in evaluation of coronary artery bypass grafting. Am J Cardiol. 1989;64:860-865. [Medline] [Order article via Infotrieve]
30. Nishimura T, Uehara T, Ishida Y, Hayashida K, Miyake Y, Shimonagata T. Is 18F-FDG a gold standard for myocardial viability? Assessment by sequential myocardial PET scan following acute myocardial infarction. J Nucl Med. 1993;34:24P. Abstract.
31.
Wijns W, Melin J, Leners N, Ferrant A, Keyeux A, Rahier
J, Cogneau M, Michel C, Bol A, Robert A, Pouleur H, Charlier A, Beckers
C. Accumulation of polymorphonuclear leukocytes in
reperfused ischemic canine myocardium: relation
with tissue viability assessed by fluorine-18-2-deoxyglucose
uptake. J Nucl Med. 1988;29:1826-1832.
32.
Ito H, Tomooka T, Sakai N, Higashino Y, Fujii K, Katoh
O, Masuyama T, Kitabatake A, Minamino T. Time course of
functional improvement in stunned myocardium in risk area
in patients with reperfused anterior infarction.
Circulation. 1993;87:355-362.
33.
Ito H, Iwakura K, Oh H, Masuyama T, Hori M, Higashino
Y, Fujii K, Minamino T. Temporal changes in myocardial perfusion
patterns in patients with reperfused anterior wall myocardial
infarction: their relation to myocardial viability.
Circulation. 1995;91:656-662.
34.
Braunwald E, Kloner RA. The stunned
myocardium: prolonged postischemic
ventricular dysfunction.
Circulation. 1982;66:1146-1152.
35. Ellis SG, Henschke CI, Sandor T, Wynne J, Braunwald E, Kloner RA. Time course of functional and biochemical recovery of myocardium salvaged by reperfusion. J Am Coll Cardiol. 1983;1:1047-1056. [Medline] [Order article via Infotrieve]
36.
Meijer A, Verheugt F, van Eenige M, Werter C.
Left ventricular function at 3 months after
successful thrombolysis: impact of reocclusion without
reinfarction on ejection fraction, regional function, and
remodeling. Circulation. 1994;90:1706-1714.
37.
Bol A, Melin JA, Vanoverschelde J, Baudhuin T,
Vogelaers D, De Pauw M, Michel C, Luxen A, Labar D, Cogneau M, Robert
A, Heyndrickx GR, Wijns W. Direct comparison of
[13N]ammonia and [15O]water
estimates of
perfusion with quantification of regional myocardial blood flow by
microspheres. Circulation. 1993;87:512-525.
38.
Rauch B, Heftus F, Grunze M, Braunwell E, Mall G,
Hasselbach W, Kubler W. Kinetics of 13N-ammonia
uptake in myocardial single cells indicating potential limitations in
its applicability as a marker of myocardial blood flow.
Circulation. 1985;71:387-393.
This article has been cited by other articles:
 |
|
 |
|
  H.-S. Lim, M.-H. Yoon, S.-J. Tahk, H.-M. Yang, B.-J. Choi, S.-Y. Choi, S.-S. Sheen, G.-S. Hwang, S.-J. Kang, and J.-H. Shin Usefulness of the index of microcirculatory resistance for invasively assessing myocardial viability immediately after primary angioplasty for anterior myocardial infarction Eur. Heart J., August 14, 2009; (2009) ehp313v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. W. Hamm, H. Möllmann, J.-P. Bassand, and F. van de Werf CHAPTER 16 Acute Coronary Syndromes ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Authors/Task Force Members, F. Van de Werf, J. Bax, A. Betriu, C. Blomstrom-Lundqvist, F. Crea, V. Falk, G. Filippatos, K. Fox, K. Huber, et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology: Eur. Heart J., December 1, 2008; 29(23): 2909 - 2945. [Full Text] [PDF]
|
|
|
|
 |
|
 V. Pineda, X. Merino, S. Gispert, P. Mahia, B. Garcia, and R. Dominguez-Oronoz No-Reflow Phenomenon in Cardiac MRI: Diagnosis and Clinical Implications Am. J. Roentgenol., July 1, 2008; 191(1): 73 - 79. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Nieman, M. D. Shapiro, M. Ferencik, C. H. Nomura, S. Abbara, U. Hoffmann, H. K. Gold, I.-K. Jang, T. J. Brady, and R. C. Cury Reperfused Myocardial Infarction: Contrast-enhanced 64-Section CT in Comparison to MR Imaging Radiology, April 1, 2008; 247(1): 49 - 56. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Sato, M. Hiroe, T. Nozato, H. Hikita, Y. Ito, H. Ohigashi, M. Tamura, A. Takahashi, M. Isobe, and K. Aonuma Early validation study of 64-slice multidetector computed tomography for the assessment of myocardial viability and the prediction of left ventricular remodelling after acute myocardial infarction Eur. Heart J., February 2, 2008; 29(4): 490 - 498. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Seyfeli, A. Abaci, M. Kula, R. Topsakal, N. K. Eryol, H. Arinc, I. Ozdogru, and A. Ergin Myocardial Blush Grade: To Evaluate Myocardial Viability in Patients With Acute Myocardial Infarction Angiology, November 1, 2007; 58(5): 556 - 560. [Abstract] [PDF]
|
|
|
|
|
|
K. M. Marques, P. Knaapen, R. Boellaard, N. Westerhof, A. A. Lammertsma, C. A. Visser, and F. C. Visser Hyperaemic microvascular resistance is not increased in viable myocardium after chronic myocardial infarction Eur. Heart J., October 1, 2007; 28(19): 2320 - 2325. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Zalewski, A. Undas, J. Godlewski, E. Stepien, and K. Zmudka No-Reflow Phenomenon After Acute Myocardial Infarction Is Associated With Reduced Clot Permeability and Susceptibility to Lysis Arterioscler Thromb Vasc Biol, October 1, 2007; 27(10): 2258 - 2265. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Sugiura, S. Nakamura, Y. Kudo, T. Okumiya, F. Yamasaki, and T. Iwasaka Clinical Factors Associated With Persistent Pericardial Effusion After Successful Primary Coronary Angioplasty Chest, August 1, 2005; 128(2): 798 - 803. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Ilkay, I. Karaca, M. Yavuzkir, M. Akbulut, and M. Pekdemir The Effect of Interventional Treatment in Acute Myocardial Infarction on ST Resolution: A Comparison of Coronary Angioplasty with Excimer Laser Angioplasty Angiology, July 1, 2005; 56(4): 377 - 384. [Abstract] [PDF]
|
|
|
|
 |
|
 E. Ilkay, I. Karaca, M. Akbulut, A E. Kilicoglu, M. Yavuzkir, and N. Arslan Excimer Laser Coronary Angioplasty in Acute Myocardial Infarction Asian Cardiovasc Thorac Ann, December 1, 2004; 12(4): 291 - 295. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W J Desmet, L V Mesotten, A F Maes, H P Heidbuchel, L A Mortelmans, and F J Van de Werf Relation between different methods for analysing ST segment deviation and infarct size as assessed by positron emission tomography Heart, August 1, 2004; 90(8): 887 - 892. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Greaves, S. R Dixon, I. O. Coker, A. I Mallet, M. Vkiran, M. J Shattock, M. J Fejka, W. W O'Neill, R. Senior, S. Redwood, et al. Influence of isoprostane F2{alpha}-III on reflow after myocardial infarction Eur. Heart J., May 2, 2004; 25(10): 847 - 853. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L Galiuto, A Lombardo, A Maseri, L Santoro, I Porto, D Cianflone, A G Rebuzzi, and F Crea Temporal evolution and functional outcome of no reflow: sustained and spontaneously reversible patterns following successful coronary recanalisation Heart, July 1, 2003; 89(7): 731 - 737. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K Greaves, S R Dixon, M Fejka, W W O'Neill, S R Redwood, M S Marber, and R Senior Myocardial contrast echocardiography is superior to other known modalities for assessing myocardial reperfusion after acute myocardial infarction Heart, February 1, 2003; 89(2): 139 - 144. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
The Task Force on the Management of Acute Myocardi, F. Van de Werf, D. Ardissino, A. Betriu, D. V. Cokkinos, E. Falk, K. A.A. Fox, D. Julian, M. Lengyel, F.-J. Neumann, et al. Management of acute myocardial infarction in patients presenting with ST-segment elevation Eur. Heart J., January 1, 2003; 24(1): 28 - 66. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Poli, R. Fetiveau, P. Vandoni, G. del Rosso, M. D'Urbano, G. Seveso, F. Cafiero, and S. De Servi Integrated Analysis of Myocardial Blush and ST-Segment Elevation Recovery After Successful Primary Angioplasty: Real-Time Grading of Microvascular Reperfusion and Prediction of Early and Late Recovery of Left Ventricular Function Circulation, July 16, 2002; 106(3): 313 - 318. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Agati, S. Funaro, M. Madonna, C. Volponi, G. Veneroso, and G. Tonti Clinical utility of contrast echocardiography in the management of patients with acute myocardial infarction Eur. Heart J. Suppl., March 1, 2002; 4(suppl_C): C27 - C34. [Abstract] [PDF]
|
|
|
|
 |
|
 G. W. Stone, M. A. Peterson, A. J. Lansky, G. Dangas, R. Mehran, and M. B. Leon Impact of normalized myocardial perfusion after successful angioplasty in acute myocardial infarction J. Am. Coll. Cardiol., February 20, 2002; 39(4): 591 - 597. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Fu, S. Goodman, W.-C. Chang, F. Van de Werf, C. B. Granger, and P. W. Armstrong Time to Treatment Influences the Impact of ST-Segment Resolution on One-Year Prognosis: Insights From the Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT-2) Trial Circulation, November 27, 2001; 104(22): 2653 - 2659. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. de Lemos and E. Braunwald ST segment resolution as a tool for assessing the efficacy of reperfusion therapy J. Am. Coll. Cardiol., November 1, 2001; 38(5): 1283 - 1294. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Hamada, T. Nishiue, S. Nakamura, T. Sugiura, H. Kamihata, H. Miyoshi, Y. Imuro, and T. Iwasaka TIMI frame count immediately after primary coronary angioplasty as a predictor of functional recovery in patients with TIMI 3 reperfused acute myocardial infarction J. Am. Coll. Cardiol., September 1, 2001; 38(3): 666 - 671. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Van de Werf New aspects of pharmacological reperfusion: from macro- to microlysis Eur. Heart J. Suppl., June 1, 2001; 3(suppl_C): C62 - C68. [Abstract] [PDF]
|
|
|
|
|
|
A. F. Maes, F. Van de Werf, L. V. Mesotten, P. B. Flamen, R. S. Kuzo, J. L. Nuyts, and L. Mortelmans Early assessment of regional myocardial blood flow and metabolism in thrombolysis in myocardial infarction flow grade 3 reperfused myocardial infarction using carbon-11-acetate J. Am. Coll. Cardiol., January 1, 2001; 37(1): 30 - 36. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Bonnemeier, F. Hartmann, U. K. H. Wiegand, F. Bode, H. A. Katus, and G. Richardt Course and prognostic implications of QT interval and QT interval variability after primary coronary angioplasty in acute myocardial infarction J. Am. Coll. Cardiol., January 1, 2001; 37(1): 44 - 50. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. J. Feldman, D. Himbert, J.-M. Juliard, G. J. Karrillon, H. Benamer, P. Aubry, O. Boudvillain, P. Seknadji, M. Faraggi, and P. G. Steg Reperfusion syndrome: relationship of coronary blood flow reserve to left ventricular function and infarct size J. Am. Coll. Cardiol., April 1, 2000; 35(5): 1162 - 1169. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Gibson, C. P. Cannon, S. A. Murphy, K. A. Ryan, R. Mesley, S. J. Marble, C. H. McCabe, F. Van de Werf, and E. Braunwald Relationship of TIMI Myocardial Perfusion Grade to Mortality After Administration of Thrombolytic Drugs Circulation, January 18, 2000; 101(2): 125 - 130. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Matetzky, M. Novikov, L. Gruberg, D. Freimark, M. Feinberg, D. Elian, I. Novikov, E. Di Segni, O. Agranat, Y. Har-Zahav, et al. The significance of persistent ST elevation versus early resolution of ST segment elevation after primary PTCA J. Am. Coll. Cardiol., December 1, 1999; 34(7): 1932 - 1938. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Claeys, J. Bosmans, L. Veenstra, P. Jorens, Herbert De Raedt, and C. J. Vrints Determinants and Prognostic Implications of Persistent ST-Segment Elevation After Primary Angioplasty for Acute Myocardial Infarction : Importance of Microvascular Reperfusion Injury on Clinical Outcome Circulation, April 20, 1999; 99(15): 1972 - 1977. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Gregorini, J. Marco, M. Kozakova, C. Palombo, G. B. Anguissola, I. Marco, M. Bernies, B. Cassagneau, A. Distante, I. M. Bossi, et al. {alpha}-Adrenergic Blockade Improves Recovery of Myocardial Perfusion and Function After Coronary Stenting in Patients With Acute Myocardial Infarction Circulation, February 2, 1999; 99(4): 482 - 490. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Bogaert, A. Maes, F. Van de Werf, H. Bosmans, M.-C. Herregods, J. Nuyts, W. Desmet, L. Mortelmans, G. Marchal, and F. E. Rademakers Functional Recovery of Subepicardial Myocardial Tissue in Transmural Myocardial Infarction After Successful Reperfusion : An Important Contribution to the Improvement of Regional and Global Left Ventricular Function Circulation, January 12, 1999; 99(1): 36 - 43. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Sakuma, Y. Hayashi, K. Sumii, M. Imazu, and M. Yamakido Prediction of short- and intermediate-term prognoses of patients with acute myocardial infarction using myocardial contrast echocardiography one day after recanalization J. Am. Coll. Cardiol., October 1, 1998; 32(4): 890 - 897. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Kupatt, H. Habazettl, S. Zahler, C. Weber, B. F Becker, K. Messmer, and E. Gerlach ACE-inhibition prevents postischemic coronary leukocyte adhesion and leukocyte-dependent reperfusion injury Cardiovasc Res, December 1, 1997; 36(3): 386 - 395. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Sklenar, G. Camarano, N. C. Goodman, S. Ismail, A. R. Jayaweera, and S. Kaul Contractile Versus Microvascular Reserve for the Determination of the Extent of Myocardial Salvage After Reperfusion: The Effect of Residual Coronary Stenosis Circulation, September 15, 1996; 94(6): 1430 - 1440. [Abstract] [Full Text]
|
|
|
|
|
|
F. M. Sheridan, P. G. Cole, and D. Ramage Leukocyte Adhesion to the Coronary Microvasculature During Ischemia and Reperfusion in an In Vivo Canine Model Circulation, May 15, 1996; 93(10): 1784 - 1787. [Abstract] [Full Text]
|
|
|
|
|
|
C. M. Gibson, C. P. Cannon, S. A. Murphy, S. J. Marble, H. V. Barron, E. Braunwald, and for the TIMI Study Group Relationship of the TIMI Myocardial Perfusion Grades, Flow Grades, Frame Count, and Percutaneous Coronary Intervention to Long-Term Outcomes After Thrombolytic Administration in Acute Myocardial Infarction Circulation, April 23, 2002; 105(16): 1909 - 1913. [Abstract] [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||